Search results (33)
« Back to PublicationsFibroblast specialisation across microanatomy in a single-cell atlas of healthy human Achilles tendon
Preprint
Cohen CJ. et al, (2025)
Exploring cellular changes in ruptured human quadriceps tendons at single-cell resolution.
Journal article
Mimpen JY. et al, (2025), J Physiol, 603, 4535 - 4554
Exploring cellular changes in ruptured human quadriceps tendons at single-cell resolution
Preprint
Mimpen J. et al, (2024)
Single nucleus and spatial transcriptomic profiling of healthy human hamstring tendon.
Journal article
Mimpen JY. et al, (2024), FASEB J, 38
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitis.
Journal article
Brown AC. et al, (2023), Cell Genom, 3
Chromosome conformation capture approaches to investigate 3D genome architecture in Ankylosing Spondylitis.
Journal article
Davidson C. et al, (2023), Front Genet, 14
FUNCTIONAL GENOMICS INVESTIGATION OF THE ANKYLOSING SPONDYLITIS ASSOCIATED LOCUS RUNX3
Conference paper
Cohen C. et al, (2022), ANNALS OF THE RHEUMATIC DISEASES, 81, 231 - 231
Functional Genomic Analysis of a RUNX3 Polymorphism Associated With Ankylosing Spondylitis.
Journal article
Vecellio M. et al, (2021), Arthritis Rheumatol, 73, 980 - 990
Perspectives on the Genetic Associations of Ankylosing Spondylitis.
Journal article
Wordsworth BP. et al, (2021), Front Immunol, 12
Disruption of c-MYC Binding and Chromosomal Looping Involving Genetic Variants Associated With Ankylosing Spondylitis Upstream of the RUNX3 Promoter.
Journal article
Cohen CJ. et al, (2021), Front Genet, 12
COMPREHENSIVE EPIGENOMIC PROFILING REVEALS DISEASE-SPECIFIC CHROMATIN STATES IN ANKYLOSING SPONDYLITIS
Conference paper
Cohen CJ. et al, (2021), CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 39, 1155 - 1155
INVESTIGATING THE ANKYLOSING SPONDYLITIS-ASSOCIATED REGULATORY SNPS AT THE RUNX3 LOCUS WITH A FUNCTIONAL GENOMICS APPROACH
Conference paper
Vecellio M. et al, (2021), ANNALS OF THE RHEUMATIC DISEASES, 80, 411 - 411
The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis.
Journal article
Watts L. et al, (2019), Genes Immun, 20, 167 - 171
Quantifying the genetic risk for the development of axial spondyloarthropathy: could this become a diagnostic tool?
Journal article
Wordsworth BP. et al, (2018), Curr Opin Rheumatol, 30, 319 - 323